İlk tanı akut koroner sendrom ile başvuran hastalarda koroner arter çaplarının prediyabet ve diyabet ile ilişkisinin incelenmesi-Reference-Cited by-同舟云学术

İlk tanı akut koroner sendrom ile başvuran hastalarda koroner arter çaplarının prediyabet ve diyabet ile ilişkisinin incelenmesi

Published:2022-06-13 Issue: Volume: Page:
ISSN:2149-8296
Container-title:Turkish Journal of Clinics and Laboratory
language:
Short-container-title:

Author:

ÖZEN Yasin¹,ÖZEKE Özcan²,ÖZBAY Mustafa Bilal³,AÇAR Burak⁴,KARAKURT Mustafa⁵,KUYUMCU Mevlüt Serdar⁶,GAYRETLİ YAYLA Kadriye⁷,YAYLA Çağrı²,ERTEM Ahmet²,ARAS Dursun²

Affiliation:

1. Sivas Numune Hastanesi

2. Ankara Şehir Hastanesi

3. Metropolitan Hospital Center

4. KOCAELI UNIVERSITY, KOCAELİ HEALTH ACADEMY

5. Kırıkkale Yüksek İhtisas

6. SULEYMAN DEMIREL UNIVERSITY, ISPARTA HEALTH ACADEMY

7. Dr. Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi

Abstract

Aim: Diabetic patients have a more severe and widespread coronary atherosclerosis, and their coronary artery diameters (CADs) are widely affected, but this has not been evaluated in prediabetics. This study investigated the effects of prediabetes on CADs in patients with acute coronary syndrome. Material and Methods: Two hundred and sixty-six patients included in this study were divided into three groups as "normal", "prediabetic" and "diabetic". Patients' CADs were calculated via the quantitative coronary angiography technique. Coronary segments were measured from the designated regions. Results: We found that both prediabetes and diabetes had similar adverse effects on vessels except the proximal RCA, unlike the normal group. We also found that the diameter of the LMCA was the most affected coronary segment, and the diameter of proximal LAD was second segment as affected mostly (p

Publisher

Turkish Journal of Clinics and Laboratory

Reference45 articles.

1. 1. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (London, England) 2004; 364 (9438):937-952.

2. 2. Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). European heart journal 2013; 34 (39):3035-3087.

3. 3. Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). European heart journal 2007; 28 (1):88-136.

4. 4. Petursson P, Herlitz J, Lindqvist J, Sjöland H, Gudbjörnsdottir S. Prevalence and severity of abnormal glucose regulation and its relation to long-term prognosis after coronary artery bypass grafting. 2013; 24 (7):577-582.

5. 5. Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. The New England journal of medicine 2011; 364 (9):829-841.